Buprenorphine Accumulation and Description of Its Metabolites During Co-Medication of Buprenorphine Transdermal System (BTDS) and Ketoconazole
Completed · Phase 1 · Has a placebo group
Conditions studied: Healthy
In brief
The purpose of this study is to assess the pharmacokinetics of buprenorphine and its metabolites in the presence and absence of ketoconazole.
Key facts
- Study ID
- NCT01259115
- Run by
- Purdue Pharma LP
- People needed
- 20
- Starts
- 2002-10-01
- Expected to finish
- 2003-06-01
- Last updated by the study team
- 2014-05-19
Who can join
Age: 18 and older, up to 54. Sex: any. Healthy volunteers: accepted.
Where it is running
- Clinical Research Center — New Orleans, Louisiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.